Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dysregulation of RNA interference components in COVID-19 patients.
Mousavi SR, Sajjadi MS, Khosravian F, Feizbakhshan S, Salmanizadeh S, Esfahani ZT, Beni FA, Arab A, Kazemi M, Shahzamani K, Sami R, Hosseinzadeh M, Salehi M, Lotfi H. Mousavi SR, et al. Among authors: shahzamani k. BMC Res Notes. 2021 Oct 29;14(1):401. doi: 10.1186/s13104-021-05816-0. BMC Res Notes. 2021. PMID: 34715923 Free PMC article.
Novel and emerging mutations of SARS-CoV-2: Biomedical implications.
Mohammadi E, Shafiee F, Shahzamani K, Ranjbar MM, Alibakhshi A, Ahangarzadeh S, Beikmohammadi L, Shariati L, Hooshmandi S, Ataei B, Javanmard SH. Mohammadi E, et al. Among authors: shahzamani k. Biomed Pharmacother. 2021 Jul;139:111599. doi: 10.1016/j.biopha.2021.111599. Epub 2021 Apr 23. Biomed Pharmacother. 2021. PMID: 33915502 Free PMC article. Review.
Vaccine design and delivery approaches for COVID-19.
Shahzamani K, Mahmoudian F, Ahangarzadeh S, Ranjbar MM, Beikmohammadi L, Bahrami S, Mohammadi E, Esfandyari S, Alibakhshi A, Javanmard SH. Shahzamani K, et al. Int Immunopharmacol. 2021 Nov;100:108086. doi: 10.1016/j.intimp.2021.108086. Epub 2021 Aug 23. Int Immunopharmacol. 2021. PMID: 34454291 Free PMC article. Review.
An update on antiviral antibody-based biopharmaceuticals.
Ahangarzadeh S, Payandeh Z, Arezumand R, Shahzamani K, Yarian F, Alibakhshi A. Ahangarzadeh S, et al. Among authors: shahzamani k. Int Immunopharmacol. 2020 Sep;86:106760. doi: 10.1016/j.intimp.2020.106760. Epub 2020 Jul 6. Int Immunopharmacol. 2020. PMID: 32645633 Free PMC article. Review.
Recent developments in antibody derivatives against colorectal cancer; A review.
Ghani S, Bahrami S, Rafiee B, Eyvazi S, Yarian F, Ahangarzadeh S, Khalili S, Shahzamani K, Jafarisani M, Bandehpour M, Kazemi B. Ghani S, et al. Among authors: shahzamani k. Life Sci. 2021 Jan 15;265:118791. doi: 10.1016/j.lfs.2020.118791. Epub 2020 Nov 19. Life Sci. 2021. PMID: 33220288 Review.
Corrigendum to: "Novel and emerging mutations of SARS-CoV-2: Biomedical implications" [Biomed. Pharmacother. 139 (2021) 111599].
Mohammadi E, Shafiee F, Shahzamani K, Ranjbar MM, Alibakhshi A, Ahangarzadeh S, Beikmohammadi L, Shariati L, Hooshmandi S, Ataei B, HaghjooyJavanmard S. Mohammadi E, et al. Among authors: shahzamani k. Biomed Pharmacother. 2021 Aug;140:111723. doi: 10.1016/j.biopha.2021.111723. Epub 2021 May 15. Biomed Pharmacother. 2021. PMID: 34001417 Free PMC article. No abstract available.
27 results